These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 27612038)

  • 1. Oxidation in the complementarity-determining regions differentially influences the properties of therapeutic antibodies.
    Dashivets T; Stracke J; Dengl S; Knaupp A; Pollmann J; Buchner J; Schlothauer T
    MAbs; 2016; 8(8):1525-1535. PubMed ID: 27612038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cysteinylation of a monoclonal antibody leads to its inactivation.
    McSherry T; McSherry J; Ozaeta P; Longenecker K; Ramsay C; Fishpaugh J; Allen S
    MAbs; 2016; 8(4):718-25. PubMed ID: 27050640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Tryptophan Oxidation in Complementarity-Determining Regions of Two Monoclonal Antibodies on Structure-Function Characterized by Hydrogen-Deuterium Exchange Mass Spectrometry and Surface Plasmon Resonance.
    Hageman T; Wei H; Kuehne P; Fu J; Ludwig R; Tao L; Leone A; Zocher M; Das TK
    Pharm Res; 2018 Dec; 36(1):24. PubMed ID: 30536043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isomerization and Oxidation in the Complementarity-Determining Regions of a Monoclonal Antibody: A Study of the Modification-Structure-Function Correlations by Hydrogen-Deuterium Exchange Mass Spectrometry.
    Yan Y; Wei H; Fu Y; Jusuf S; Zeng M; Ludwig R; Krystek SR; Chen G; Tao L; Das TK
    Anal Chem; 2016 Feb; 88(4):2041-50. PubMed ID: 26824491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural basis for antigen recognition by methylated lysine-specific antibodies.
    Ishii M; Nakakido M; Caaveiro JMM; Kuroda D; Okumura CJ; Maruyama T; Entzminger K; Tsumoto K
    J Biol Chem; 2021; 296():100176. PubMed ID: 33303630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of a high-affinity human antibody with a disulfide bridge in the third complementarity-determining region of the heavy chain.
    Almagro JC; Raghunathan G; Beil E; Janecki DJ; Chen Q; Dinh T; LaCombe A; Connor J; Ware M; Kim PH; Swanson RV; Fransson J
    J Mol Recognit; 2012 Mar; 25(3):125-35. PubMed ID: 22407976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The critical role of arginine residues in the binding of human monoclonal antibodies to cardiolipin.
    Giles I; Lambrianides N; Latchman D; Chen P; Chukwuocha R; Isenberg D; Rahman A
    Arthritis Res Ther; 2005; 7(1):R47-56. PubMed ID: 15642142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Succinimide formation at Asn 55 in the complementarity determining region of a recombinant monoclonal antibody IgG1 heavy chain.
    Yan B; Steen S; Hambly D; Valliere-Douglass J; Vanden Bos T; Smallwood S; Yates Z; Arroll T; Han Y; Gadgil H; Latypov RF; Wallace A; Lim A; Kleemann GR; Wang W; Balland A
    J Pharm Sci; 2009 Oct; 98(10):3509-21. PubMed ID: 19475547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isomerization in the CDR2 of a monoclonal antibody: Binding analysis and factors that influence the isomerization rate.
    Dick LW; Qiu D; Wong RB; Cheng KC
    Biotechnol Bioeng; 2010 Feb; 105(3):515-23. PubMed ID: 19806678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aggregation-resistant domain antibodies engineered with charged mutations near the edges of the complementarity-determining regions.
    Perchiacca JM; Ladiwala AR; Bhattacharya M; Tessier PM
    Protein Eng Des Sel; 2012 Oct; 25(10):591-601. PubMed ID: 22843678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances in Antibody Design.
    Tiller KE; Tessier PM
    Annu Rev Biomed Eng; 2015; 17():191-216. PubMed ID: 26274600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In silico prediction of post-translational modifications in therapeutic antibodies.
    Vatsa S
    MAbs; 2022; 14(1):2023938. PubMed ID: 35040751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-Function Assessment and High-Throughput Quantification of Site-Specific Aspartate Isomerization in Monoclonal Antibody Using a Novel Analytical Tool Kit.
    Zhou K; Cao X; Bautista J; Chen Z; Hershey N; Ludwig R; Tao L; Zeng M; Das TK
    J Pharm Sci; 2020 Jan; 109(1):422-428. PubMed ID: 31469998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Augmented Binary Substitution: Single-pass CDR germ-lining and stabilization of therapeutic antibodies.
    Townsend S; Fennell BJ; Apgar JR; Lambert M; McDonnell B; Grant J; Wade J; Franklin E; Foy N; Ní Shúilleabháin D; Fields C; Darmanin-Sheehan A; King A; Paulsen JE; Hickling TP; Tchistiakova L; Cunningham O; Finlay WJ
    Proc Natl Acad Sci U S A; 2015 Dec; 112(50):15354-9. PubMed ID: 26621728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular Characterization of Two Monoclonal Antibodies against the Same Epitope on B-Cell Receptor Associated Protein 31.
    Kim WT; Shin S; Hwang HJ; Kim MK; Jung HS; Park H; Ryu CJ
    PLoS One; 2016; 11(12):e0167527. PubMed ID: 27907150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of methionine oxidation risk in monoclonal antibodies using a machine learning method.
    Sankar K; Hoi KH; Yin Y; Ramachandran P; Andersen N; Hilderbrand A; McDonald P; Spiess C; Zhang Q
    MAbs; 2018; 10(8):1281-1290. PubMed ID: 30252602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Computational design of an epitope-specific Keap1 binding antibody using hotspot residues grafting and CDR loop swapping.
    Liu X; Taylor RD; Griffin L; Coker SF; Adams R; Ceska T; Shi J; Lawson AD; Baker T
    Sci Rep; 2017 Jan; 7():41306. PubMed ID: 28128368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Affinity maturation of a novel antagonistic human monoclonal antibody with a long VH CDR3 targeting the Class A GPCR formyl-peptide receptor 1.
    Douthwaite JA; Sridharan S; Huntington C; Hammersley J; Marwood R; Hakulinen JK; Ek M; Sjögren T; Rider D; Privezentzev C; Seaman JC; Cariuk P; Knights V; Young J; Wilkinson T; Sleeman M; Finch DK; Lowe DC; Vaughan TJ
    MAbs; 2015; 7(1):152-66. PubMed ID: 25484051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Engineering an anti-CD52 antibody for enhanced deamidation stability.
    Qiu H; Wei R; Jaworski J; Boudanova E; Hughes H; VanPatten S; Lund A; Day J; Zhou Y; McSherry T; Pan CQ; Sendak R
    MAbs; 2019 Oct; 11(7):1266-1275. PubMed ID: 31199181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Qualification of a Quantitative Method for Monitoring Aspartate Isomerization of a Monoclonal Antibody by Focused Peptide Mapping.
    Cao M; Mo WD; Shannon A; Wei Z; Washabaugh M; Cash P
    PDA J Pharm Sci Technol; 2016 11/12; 70(6):490-507. PubMed ID: 27091886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.